Table 2 Laboratory findings and comparison between rebleeding and no-rebleeding group
Characteristic | Total | Rebleeding | Non-rebleeding | P |
|---|---|---|---|---|
N = 386 | N = 48 | N = 338 | ||
Hemoglobin level on admission [g/L, median (IQR)] | 78.5 (64–98) | 74.5 (59.5–93) | 79 (66–98) | 0.124 |
White cell count [× 109/L, median (IQR)] | 7.85 (5.65–11..11) | 9.35 (7.12–12.81) | 7.59 (5.65–10.92) | 0.019 |
Platelet [× 109/L, median (IQR)] | 167 (116–218) | 132.5 (89.5–192) | 172.5 (121–219) | 0.015 |
Blood urea nitrogen [mmol/L, median (IQR)] | 8.3 (5.7–12.3) | 10.25 (5.65–15.15) | 8.2 (5.7–11.94) | 0.092 |
Creatinine [μmol/L, median (IQR)] | 74.2 (61.3–90.8) | 72.6 (59.9–107.6) | 74.9 (61.3–89.3) | 0.596 |
Albumin [g/L, median (IQR)] | 32 (27.9–37) | 28.8 (24.9–32) | 32.4 (28.8–37.2) | 0.001 |
Albumin [ALB ≤ 30 g/L, No. (%)] | 124 (32.1) | 25 (52.1) | 99 (29.3) | 0.002 |
Prothrombin time [s, median (IQR)] | 11.8 (11–13) | 13.1 (11.6–16.2) | 11.7 (11–12.8) | 0.001 |
APTT, median (IQR) | 28.65 (24.5–33.1) | 32.15 (27.15–50.5) | 28.35 (24.5–32.5) | 0.001 |
International normalized ratio [INR > 1.5, No. (%)] | 15 (3.9) | 8 (16.7) | 7 (2.1) | 0.001 |